Agenda | Speaker |
|---|---|
Welcome and Introduction | Chair: Guy Young, US |
First Results From the MOTIVATE Study | Carmen Escuriola Ettingshausen, DE |
FVIII Binding to Platelets: Are There Differences Between the Products? | Viola Vogel, CH |
Generating Long-Term Data on Bone and Joint Health: The PROVE Study | Yesim Dargaud, FR |
Exploring the Functionality of Endothelial Cells in Haemophilia A | Antonia Follenzi, IT |
Q&A | Speakers and Audience |
Thailand23/06/2024
ISTH 2024
Octapharma Under the Spotlight Symposium
:quality(80))
Learn About Tomorrow's Advances Today - Breakthrougs in All-Round Bleed Protection
Sunday, June 23, 2024
12:15 - 13:30 ICT
Room 208
Join us to learn about clinical and scientific advances in care for patients with haemophilia A. Results from the first interim analysis of the MOTIVATE study in ITI will be presented, alongside novel scientific data examining the role of FVIII in platelet binding, endothelial cell binding and joint and bone health.
Symposium programme
This symposium is for healthcare professionals only and is organised and sponsored by Octapharma. This is a promotional symposium and Octapharma products will be discussed. Before prescribing any product, always refer to local materials such as the prescribing information and/or the summary of product characteristics.
Meet the speakers
Chair: Guy Young
US
Carmen Escuriola Ettingshausen
DE
Viola Vogel
CH
Yesim Dargaud
FR
Antonia Follenzi
IT
:quality(80))
Join live on One Source
In case you cannot join us in person for the ISTH congress in Bangkok, we invite you to watch our symposium live on One Source, Octapharma's online platform.
The event is for healthcare professional only.
:quality(80))